# Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques

> **NCT02992756** · PHASE3 · TERMINATED · sponsor: **IVI Bilbao** · enrollment: 51 (actual)

## Conditions studied

- Low Ovarian Reserve

## Interventions

- **DRUG:** Growth Factors

## Key facts

- **NCT ID:** NCT02992756
- **Lead sponsor:** IVI Bilbao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-29
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Due to the difficulty in meeting the selection criteria by preventing continued recruitment to the trial. This has made recruitment more difficult and has prolonged the recruitment time to more than two years from the initially planned end of study
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992756, "Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02992756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*